The FDA is expected to decide on treatments for bullous pemphigoid, hereditary angioedema, HIV PrEP, ovarian cancer, and RSV.

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis.

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV ... the only preventative option and required monthly injections to sustain its protective effect.

The Vermont pandemic death total stands at 1,289 as of April 19, 2025, with 1 reported death from the previous week (the most ...

The company plans to introduce Beyfortus, which contains the monoclonal antibody nirsevimab, in a prefilled injection used ...

The researchers said that efficacy of nirsevimab seen in the controlled settings of a clinical trial may not fully reflect ...

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis.